Axolap-S 1.5 Injection
Marketer
Mosfet Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Axolap-S 1.5 Injection
Combiflox-1.5 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus preventing infection spread. Administration must be strictly under a doctor's guidance; adhere to the prescribed schedule without interruption. Complete the full course, even with symptom improvement; premature cessation can compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects require immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and ample hydration are crucial for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Primary Ingredients of Axolap-S 1.5 Injection
No text provided to rephrase.
Uses of Axolap-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Axolap-S 1.5 Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Axolap-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Axolap-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Axolap-S 1.5 Injection works:
Axolap-S 1.5 Injection merges Ceftriaxone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam complements this by countering bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Axolap-S 1.5 Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Axolap-S 1.5 is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; however, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Axolap-S 1.5 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued until the maternal course of treatment concludes and the medication is fully cleared from the patient's system.
DrivingUNSAFE
Axolap-S 1.5 Injection can cause drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Axolap-S 1.5 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Axolap-S 1.5 Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Axolap-S 1.5 Injection isn't advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Axolap-S 1.5 Injection :
Omit a dose of Axolap-S 1.5 Injection? Seek your physician's advice.
Facts to Know About Axolap-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently